| __timestamp | Catalyst Pharmaceuticals, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 10337679 |
| Thursday, January 1, 2015 | 8597010 | 18187286 |
| Friday, January 1, 2016 | 7910260 | 24758063 |
| Sunday, January 1, 2017 | 7304399 | 23666957 |
| Monday, January 1, 2018 | 15875961 | 30099855 |
| Tuesday, January 1, 2019 | 36881187 | 64947625 |
| Wednesday, January 1, 2020 | 44233754 | 186363444 |
| Friday, January 1, 2021 | 49628000 | 272611040 |
| Saturday, January 1, 2022 | 58183000 | 358782000 |
| Sunday, January 1, 2023 | 133710000 | 409864000 |
Infusing magic into the data realm
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Catalyst Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, Catalyst Pharmaceuticals saw a steady increase in SG&A expenses, peaking at a 2,887% rise by 2023. In contrast, Intra-Cellular Therapies experienced a more dramatic surge, with expenses growing by 3,865% over the same period. This divergence highlights the strategic choices each company has made in scaling their operations and managing overheads. While Catalyst Pharmaceuticals has maintained a more conservative growth trajectory, Intra-Cellular Therapies has aggressively expanded its administrative footprint. Understanding these trends provides valuable insights into how each company navigates the financial landscape of the biopharma industry.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Catalyst Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Pharming Group N.V.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and MannKind Corporation
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Blueprint Medicines Corporation and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.: SG&A Spending Patterns Compared